Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06298110Phase 3Not yet recruiting
Phase 3, randomised, open-label trial of autologous platelet-rich plasma in surgical wound (2 arms), sponsored by Helwan University. Primary endpoint: Changes in wound healing at Day 30. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06298110.